These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27594563)

  • 21. Adipose tissue and metabolic syndrome: too much, too little or neither.
    Grundy SM
    Eur J Clin Invest; 2015 Nov; 45(11):1209-17. PubMed ID: 26291691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipidomic profiling reveals early-stage metabolic dysfunction in overweight or obese humans.
    Mousa A; Naderpoor N; Mellett N; Wilson K; Plebanski M; Meikle PJ; de Courten B
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Mar; 1864(3):335-343. PubMed ID: 30586632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions.
    de Oliveira Dos Santos AR; de Oliveira Zanuso B; Miola VFB; Barbalho SM; Santos Bueno PC; Flato UAP; Detregiachi CRP; Buchaim DV; Buchaim RL; Tofano RJ; Mendes CG; Tofano VAC; Dos Santos Haber JF
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular changes in hepatic metabolism in ZDSD rats-A new polygenic rodent model of obesity, metabolic syndrome, and diabetes.
    Han L; Bittner S; Dong D; Cortez Y; Bittner A; Chan J; Umar M; Shen WJ; Peterson RG; Kraemer FB; Azhar S
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165688. PubMed ID: 31987840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventive effect of geniposide on metabolic disease status in spontaneously obese type 2 diabetic mice and free fatty acid-treated HepG2 cells.
    Kojima K; Shimada T; Nagareda Y; Watanabe M; Ishizaki J; Sai Y; Miyamoto K; Aburada M
    Biol Pharm Bull; 2011; 34(10):1613-8. PubMed ID: 21963504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial dysfunction in metabolic syndrome.
    Prasun P
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165838. PubMed ID: 32428560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of the endocrine system in the pathogenesis of non-alcoholic fatty liver disease].
    Hagymási K; Reismann P; Rácz K; Tulassay Z
    Orv Hetil; 2009 Nov; 150(48):2173-81. PubMed ID: 19923096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift.
    Nolan CJ; Prentki M
    Diab Vasc Dis Res; 2019 Mar; 16(2):118-127. PubMed ID: 30770030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids.
    Smith U; Kahn BB
    J Intern Med; 2016 Nov; 280(5):465-475. PubMed ID: 27699898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin action and resistance in obesity and type 2 diabetes.
    Czech MP
    Nat Med; 2017 Jul; 23(7):804-814. PubMed ID: 28697184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular effects of disturbed insulin activity in metabolic syndrome and in type 2 diabetic patients.
    Forst T; Hohberg C; Pfützner A
    Horm Metab Res; 2009 Feb; 41(2):123-31. PubMed ID: 19214922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome.
    Wimalawansa SJ
    J Steroid Biochem Mol Biol; 2018 Jan; 175():177-189. PubMed ID: 27662816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance and the metabolic syndrome.
    Lann D; Gallagher E; Leroith D
    Minerva Med; 2008 Jun; 99(3):253-62. PubMed ID: 18497723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 Diabetes.
    Willeit P; Skroblin P; Moschen AR; Yin X; Kaudewitz D; Zampetaki A; Barwari T; Whitehead M; Ramírez CM; Goedeke L; Rotllan N; Bonora E; Hughes AD; Santer P; Fernández-Hernando C; Tilg H; Willeit J; Kiechl S; Mayr M
    Diabetes; 2017 Feb; 66(2):347-357. PubMed ID: 27899485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low plasma adropin concentrations increase risks of weight gain and metabolic dysregulation in response to a high-sugar diet in male nonhuman primates.
    Butler AA; Zhang J; Price CA; Stevens JR; Graham JL; Stanhope KL; King S; Krauss RM; Bremer AA; Havel PJ
    J Biol Chem; 2019 Jun; 294(25):9706-9719. PubMed ID: 30988006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players.
    Zimmet P; Boyko EJ; Collier GR; de Courten M
    Ann N Y Acad Sci; 1999 Nov; 892():25-44. PubMed ID: 10842650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natriuretic peptides in the control of lipid metabolism and insulin sensitivity.
    Verboven K; Hansen D; Jocken JWE; Blaak EE
    Obes Rev; 2017 Nov; 18(11):1243-1259. PubMed ID: 28901677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet beta-cells and enhances insulin secretion.
    Buchanan CM; Phillips AR; Cooper GJ
    Biochem J; 2001 Dec; 360(Pt 2):431-9. PubMed ID: 11716772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.